Findings from a new study, led by researchers at Dartmouth's Geisel School of Medicine and published in Nature Immunology, have uncovered key functional differences in macrophages—a type of white blood cell that plays a ...
May 2, 2024
0
16
Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to make the process more efficient using artificial intelligence. The ...
Apr 25, 2024
0
24
Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson's disease treatments.
Apr 17, 2024
0
77
Hydronephrosis is a common congenital anomaly that is increasingly identified during prenatal ultrasound. Although ultrasound is also the first-line test to screen for hydronephrosis in infants, it is poor at determining ...
Apr 5, 2024
0
2
Researchers at Tel Aviv University developed a new therapeutic strategy based on existing medications to inhibit bone metastasis in breast cancer patients. Using both an animal model and tissue samples from patients in Israel ...
Apr 2, 2024
0
35
The eye is a unique window to overall health. Its associated medical imaging has great characteristics, such as being non-invasive, convenient, and rich in information, which offers significant potential for developing new ...
Mar 22, 2024
0
1
From the very first weeks of life, countless connections are forged between neurons to ensure the propagation of nerve signals. These connections gradually shape the final architecture of the brain, known as the connectome. ...
Mar 8, 2024
0
58
A research team led by the Institut de Neurociències at the UAB has managed to generate and validate a new animal model. This model enables the examination of the initial phases of Parkinson's disease, occurring prior to ...
Mar 4, 2024
0
1
Researchers at the University of Massachusetts Amherst recently released a first-of-its-kind study focusing on the rare autoimmune disorder aplastic anemia to understand how a subset of cells might be trained to correct the ...
Feb 27, 2024
0
0
In experiments with lab-grown brain cells and mouse models, scientists at Johns Hopkins Medicine say they have discovered that a cell surface protein called Lag3 is not only a biological target for FDA-approved drugs that ...
Feb 23, 2024
0
90
